Leading healthcare information technology (HCIT) solutions
provider,
Cerner Corporation
(
CERN
) recently revealed the acquisition of Labotix Automation Inc.
Labotix is a leader in providing flexible and open automation
solutions to the clinical laboratory setting. This acquisition is
likely to provide expertise for supporting the high volume
testing market.
According to Cerner, the acquisition of Labotix has placed the
company in a strategic position from where it can focus on
helping clients through automation options, as well as reducing
errors while upgrading capacity of laboratory processing.
Labotix Automation, started in 1991, is an open automation
solution, which functions with all devices prevailing in the
market. The company's worldwide installations have been operating
and adapting to changes for more than two decades. Through its
worldwide operations, Labotix gained proficiency, knowledge and
trust to meet the needs of a laboratory, irrespective of its
size.
Now that the acquisition is complete, Cerner aims to offer
Labotix's expertise to its global client-base by enhancing
operations in laboratories through assimilation of Cerner's
platforms. According to Labotix the commitment of Cerner combined
with its expertise is likely to bring about accuracy and better
results.
Cerner remains the trendsetter among pure-play, publicly
traded healthcare IT (HCIT) vendors. The company is diversified
not only on a global basis but serves both hospitals and
ambulatory outfits. Its integrated solutions have captured market
share. While greenfield opportunities are shrinking, the
replacement market is growing.
We believe long-term investors may consider Cerner, as it
serves a sizeable installed hospital base that requires composite
clinically-oriented applications complying with "meaningful use"
requirements, reimbursement difficulties and complicated coding
challenges. The company has long-standing, integrated and
seamless solutions for both inpatient and ambulatory
settings.
On the negative side, the federal Stimulus program is
gradually winding down. Cerner faces stiff competition from
established HCIT players, such as
Athenahealth
(
ATHN
). Cerner carries a Zacks Rank #3 (Hold) . However, we are more
positive about other stocks such as
Cyberonics Inc.
(
CYBX
) and
Given Imaging Ltd.
(
GIVN
) both of which carry a Zacks Rank #1 (Strong Buy) and are
expected to do well.
ATHENAHEALTH IN (ATHN): Free Stock Analysis
Report
CERNER CORP (CERN): Free Stock Analysis
Report
CYBERONICS INC (CYBX): Free Stock Analysis
Report
GIVEN IMAGING (GIVN): Free Stock Analysis
Report
To read this article on Zacks.com click here.
Zacks Investment
Research